See how your answers relate to your colleagues'.

In your experience, what have most studies about CGM demonstrated?
HbA1c is lower in CGM users regardless of age or type of insulin delivery
Patients using MDI + CGM have greater reductions in HbA1c1c than those using CSII + CGM
Reductions in glycemic variability and time spent in hypoglycemia are not significantly different between SAP and MDI/RT-CGM therapy groups
All of the above

Submit is supported by independent educational grants from Ascensia Diabetes Care, Insulet Corporation, Madrigal Pharmaceuticals, Medtronic and Stanford University.
©2023 CogniMed Inc. All rights reserved.